- Home
- ESTA vs MIST Comparison
ESTA vs MIST Comparison
Compare ESTA & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESTA
- MIST
- Stock Information
- Founded
- ESTA 2004
- MIST 2003
- Country
- ESTA Costa Rica
- MIST Canada
- Employees
- ESTA N/A
- MIST N/A
- Industry
- ESTA Industrial Specialties
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- ESTA Health Care
- MIST Health Care
- Exchange
- ESTA Nasdaq
- MIST Nasdaq
- Market Cap
- ESTA 982.3M
- MIST 89.8M
- IPO Year
- ESTA 2018
- MIST N/A
- Fundamental
- Price
- ESTA $46.11
- MIST $2.17
- Analyst Decision
- ESTA Buy
- MIST Strong Buy
- Analyst Count
- ESTA 6
- MIST 2
- Target Price
- ESTA $55.50
- MIST $7.50
- AVG Volume (30 Days)
- ESTA 393.3K
- MIST 638.1K
- Earning Date
- ESTA 08-05-2025
- MIST 08-07-2025
- Dividend Yield
- ESTA N/A
- MIST N/A
- EPS Growth
- ESTA N/A
- MIST N/A
- EPS
- ESTA N/A
- MIST N/A
- Revenue
- ESTA $170,235,000.00
- MIST N/A
- Revenue This Year
- ESTA $27.10
- MIST N/A
- Revenue Next Year
- ESTA $24.55
- MIST N/A
- P/E Ratio
- ESTA N/A
- MIST N/A
- Revenue Growth
- ESTA 9.27
- MIST N/A
- 52 Week Low
- ESTA $26.56
- MIST $0.63
- 52 Week High
- ESTA $52.41
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- ESTA 72.79
- MIST 74.51
- Support Level
- ESTA $34.34
- MIST $1.86
- Resistance Level
- ESTA $38.84
- MIST $1.97
- Average True Range (ATR)
- ESTA 2.39
- MIST 0.12
- MACD
- ESTA 0.69
- MIST 0.02
- Stochastic Oscillator
- ESTA 92.97
- MIST 93.22
About ESTA Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).